MARKET

JAGX

JAGX

Jaguar Health Inc
NASDAQ
1.280
-0.070
-5.19%
After Hours: 1.280 0 0.00% 18:47 07/26 EDT
OPEN
1.330
PREV CLOSE
1.350
HIGH
1.390
LOW
1.250
VOLUME
930.14K
TURNOVER
0
52 WEEK HIGH
41.76
52 WEEK LOW
1.250
MARKET CAP
8.23M
P/E (TTM)
-0.0163
1D
5D
1M
3M
1Y
5Y
1D
Jaguar stock plunges 60% on failed Phase 3 study for crofelemer
Jaguar Health's stock plunges 60% on failed Phase 3 study for crofelemer. The drug failed to meet its primary endpoint in adult cancer patients. The company had been testing the drug for the symptomatic relief of diarrhea in AIDS/HIV patients.
Seeking Alpha · 3d ago
Gold Moves Higher; Coca-Cola Increases FY24 Forecast
U.S. Stocks traded slightly higher toward the end of trading on Tuesday. The Dow Jones gained more than 50 points and the NASDAQ rose 0.20%. Coca-Cola Company reported better-than-expected second-quarter results and raised its guidance. Azitra, Inc. Shares shot up 326% after being granted a patent for treatment of atopic dermatitis.
Benzinga · 3d ago
Sector Update: Health Care Stocks Advance in Afternoon Trading
NASDAQ · 3d ago
Why Is Azitra (AZTR) Stock Up 315% Today?
Azitra (NYSEMKT:AZTR) stock is up 315% as of Tuesday morning. Azitra announced three newly allowed patents in the U.S., Canada, and China. The early-stage biopharmaceutical company also announced updates on its patents. AZTR stock is taking off on Tuesday after a patent was issued on July 16 for atopic dermatitis. There are more stock market news stories traders will want to see on Tuesday. See Serve Robotics (NASDAQ: SERV) stock and Jaguar Health (JAGX) shares today.
Investorplace · 3d ago
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Comcast Corporation shares fell 6.1% to $37.12 on Tuesday. The company reported worse-than-expected second-quarter sales results. Azitra, Inc. Shares jumped 529% after company received patent for treatment of atopic dermatitis. Other stocks moving in the mid-day session include GE Aerospace and Owens & Minor.
Benzinga · 3d ago
Why Is Serve Robotics (SERV) Stock Down Today?
Serve Robotics is selling 2.5 million pre-funded warrants for SERV stock for $6 each. The company is expecting to raise $15 million from this private offering. SERV stock is down 8.2% as of Tuesday morning. Jaguar Health, AMC Entertainment and Adial Pharmaceuticals stock are also down on Tuesday.
Investorplace · 3d ago
Why Jaguar Health Stock Is Crashing
Jaguar Health, Inc. Shares are falling Tuesday after the company announced its phase 3 OnTarget trial results for crofelemer did not meet its primary endpoint. The drug is an FDA-approved prescription drug for the symptomatic relief of diarrhea in adult HIV/AIDS patients.
Benzinga · 3d ago
Why Is Jaguar Health (JAGX) Stock Down 55% Today?
Jaguar Health (NASDAQ:JAGX) stock is down 55.2% on Tuesday after a clinical trial fails to meet its primary endpoint. The failed clinical trial of crofelemer is a blow to JAGX stock. AMC Entertainment (NYSE:AMC), Adial Pharmaceuticals and CrowdStrike are also in the news today. We have all of the hottest stock market news on Tuesday.
Investorplace · 3d ago
More
About JAGX
Jaguar Health, Inc. is a commercial-stage pharmaceuticals company. The Company is focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress. It operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. The human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. The Canalevia-CA1 is for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Its subsidiary Napo Pharmaceuticals, Inc. focuses on developing and commercializing human prescription pharmaceuticals.

Webull offers Jaguar Health Inc stock information, including NASDAQ: JAGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAGX stock methods without spending real money on the virtual paper trading platform.